Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sun Pharmaceutical Industries is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company globally. The company manufactures and markets a vast portfolio of generic and specialty medicines targeting a wide range of chronic and acute treatments, including oncology, dermatology, cardiology, and neuro-psychiatry. Sun Pharma has transitioned from a pure generics player to a specialty-focused organization, with key branded products such as Ilumya for plaque psoriasis and Cequa for dry eye disease. With over 40 manufacturing facilities across the globe, the company serves more than 100 markets with high-quality, affordable medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sun Enterprises.